Literature DB >> 9561066

Multisite study of the safety and efficacy of LumenHance, a new gastrointestinal contrast agent for MRI of the abdomen and pelvis.

W C Small1, D D Macchi, J R Parker, M E Bernardino.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9561066     DOI： 10.1016/s1076-6332(98)80087-1

Source DB:  PubMed          Journal:  Acad Radiol        ISSN： 1076-6332            Impact factor:   3.173


× No keyword cloud information.
  2 in total

1.  Manganese-based MRI contrast agents: past, present and future.

Authors:  Dipanjan Pan; Anne H Schmieder; Samuel A Wickline; Gregory M Lanza
Journal:  Tetrahedron       Date:  2011-11-04       Impact factor: 2.457

2.  MR imaging of the small bowel with increasing concentrations of an oral osmotic agent.

Authors:  Arne S Borthne; Michael Abdelnoor; Johan C Hellund; Jonn T Geitung; Trygve Storaas; Kjell I Gjesdal; Nils-E Kløw
Journal:  Eur Radiol       Date:  2005-02-08       Impact factor: 5.315
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.